Renal transplantation in patients with aa amyloidosis nephropathy: Results from a french multicenter study

American Journal of Transplantation

Volumn 11, Issue 11, 2011, Pages 2423-2431

  Kofman, T ^a   Grimbert, P ^a   Canoui Poitrine F ^a,b   Zuber, J ^c   Garrigue, V ^d   Mousson, C ^e   Frimat, L ^f   Kamar, N ^g   Couvrat, G ^h   Bouvier, N ⁱ   Albano, L ^j   Le Thuaut, A ^a,b   Pillebout, E ^k   Choukroun, G ^l   Couzi, L ^m   Peltier, J ⁿ   Mariat, C ^o   Delahousse, M ^p   Buchler, M ^q   Le Pogamp, P ^r   Bridoux, F ^s   Pouteil Noble, C ^t   Lang, P ^a   Audard, V ^a   more..

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d UNIV MONTPELLIER   (France)

^e DIJON UNIVERSITY HOSPITAL   (France)

^f UNIVERSITY HOSPITAL OF NANCY   (France)

^g CHU RANGUEIL   (France)

^h UNIVERSITÉ DE NANTES   (France)

ⁱ CHU Clemenceau   (France)

^j UNIVERSITY HOSPITAL OF NICE   (France)

^k SAINT LOUIS HOSPITAL   (France)

^l Universitaire d'Amiens   (France)

^m BORDEAUX UNIVERSITY HOSPITAL   (France)

ⁿ HÔPITAL TENON   (France)

^o UNIVERSITÉ JEAN MONNET   (France)

^p FOCH HOSPITAL   (France)

^q UNIVERSITÉ DE TOURS   (France)

^r PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^s UNIVERSITÉ DE POITIERS   (France)

^t UNIVERSITÉ DE LYON   (France)

more..

Author keywords

AA amyloidosis nephropathy; Graft survival; Infectious episodes; Recurrence

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HUMAN; KIDNEY AMYLOIDOSIS; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY (TOPIC); OVERALL SURVIVAL; PRIORITY JOURNAL; SEPSIS; TREATMENT OUTCOME;

ADULT; AMYLOIDOSIS; CARDIOVASCULAR DISEASES; FEMALE; GRAFT SURVIVAL; HUMANS; INFECTION; KAPLAN-MEIER ESTIMATE; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84857192490     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03620.x     Document Type: Article

References (30)

1. Merlini G, Bellotti V.Molecular mechanisms of amyloidosis. N Engl J Med 2003; 349: 583-596. (Pubitemid 36951371)
2. Rajkumar SV, Gertz MA. Advances in the treatment of amyloidosis. N Engl J Med 2007; 356: 2413-2415. (Pubitemid 46883777)
3. Westermark P, Benson MD, Buxbaum JN, et al. Amyloid: Toward terminology clarification. Report from the Nomenclature Committee of the International Society of Amyloidosis. Amyloid 2005; 12: 1-4. (Pubitemid 40896938)
4. Dember LM. Amyloidosis-associated kidney disease. J Am Soc Nephrol 2006; 17: 3458-3471. (Pubitemid 44865288)
5. Lachmann HJ, Goodman HJ, Gilbertson JA, et al. Natural history and outcome in systemic AA amyloidosis. N Engl J Med 2007; 356: 2361-2371. (Pubitemid 46883770)
6. Pepys MB. Amyloidosis. Annu Rev Med 2006; 57: 223-241. (Pubitemid 43261989)
7. Westermark GT,Westermark P. Serum amyloid A and protein AA: Molecular mechanisms of a transmissible amyloidosis. FEBS Lett 2009; 583: 2685-2690.
8. Gertz MA, Kyle RA. Secondary systemic amyloidosis: Response and survival in 64 patients. Medicine (Baltimore) 1991; 70: 246-256.
9. Joss N, McLaughlin K, Simpson K, Boulton-Jones JM. Presentation, survival and prognostic markers in AA amyloidosis. Quart J Med 2000; 93: 535-542. (Pubitemid 30627402)
10. Cohen SL, Boner G, Shmueli D, Yusim A, Rosenfeld J, Shapira Z. Cyclosporin: Poorly tolerated in familial Mediterranean fever. Nephrol Dial Transplant 1989; 4: 201-204. (Pubitemid 19113605)
11. Sherif AM, Refaie AF, Sobh MA, Mohamed NA, Sheashaa HA, Ghoneim MA. Long-term outcome of live donor kidney transplantation for renal amyloidosis. Am J Kidney Dis 2003; 42: 370-375. (Pubitemid 36944447)
12. Heering P, Hetzel R, Grabensee B, Opelz G. Renal transplantation in secondary systemic amyloidosis. Clin Transplant 1998; 12: 159-164. (Pubitemid 28269235)
13. Haq A, Hussain S, Meskat B, Mohan P, Conlon P, Hickey DP. Complications of renal transplantation in patients with amyloidosis. Transplant Proc 2007; 39: 120-124. (Pubitemid 46175942)
14. Pelle G, Vimont S, Levy PP, et al. Acute pyelonephritis represents a risk factor impairing long-term kidney graft function. Am J Transplant 2007; 7: 899-907. (Pubitemid 46481188)
15. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612.
16. Potysova Z, Merta M, Tesar V, Jancova E, Honsova E, Rysava R. Renal AA amyloidosis: Survey of epidemiologic and laboratory data from one nephrology centre. Int Urol Nephrol 2009; 41: 941-945.
17. Tanaka F, Migita K, Honda S, et al. Clinical outcome and survival of secondary (AA) amyloidosis. Clin Exp Rheumatol 2003; 21: 343-346. (Pubitemid 36747830)
18. Dispenzieri A, Gertz MA, Kyle RA, et al. Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: A staging system for primary systemic amyloidosis. J Clin Oncol 2004; 22: 3751-3757. (Pubitemid 41095215)
19. Mekinian A, Lions C, Leleu X, et al. Prognosis assessment of cardiac involvement in systemic AL amyloidosis by magnetic resonance imaging. Am J Med; 123: 864-868.
20. Audard V, Matignon M, Weiss L, et al. Successful long-term outcome of the first combined heart and kidney transplant in a patient with systemic Al amyloidosis. Am J Transplant 2009; 9: 236-240.
21. Sattianayagam PT, Gibbs SD, Pinney JH, et al. Solid organ transplantation in AL amyloidosis. Am J Transplant; 10: 2124-2131.
22. Bergesio F, Ciciani AM, Manganaro M, et al. Renal involvement in systemic amyloidosis: An Italian collaborative study on survival and renal outcome. Nephrol Dial Transplant 2008; 23: 941-951.
23. Bollee G, Guery B, Joly D, et al. Presentation and outcome of patients with systemic amyloidosis undergoing dialysis. Clin J Am Soc Nephrol 2008; 3: 375-381.
24. Ueda M, Ando Y, Nakamura M, et al. FK506 inhibits murine AA amyloidosis: Possible involvement of T cells in amyloidogenesis. J Rheumatol 2006; 33: 2260-2270. (Pubitemid 44749787)
25. Zemer D, Pras M, Sohar E, Modan M, Cabili S, Gafni J. Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med 1986; 314: 1001-1005. (Pubitemid 16138694)
26. Livneh A, Zemer D, Siegal B, Laor A, Sohar E, Pras M. Colchicine prevents kidney transplant amyloidosis in familial Mediterranean fever. Nephron 1992; 60: 418-422.
27. Cazeneuve C, Sarkisian T, Pecheux C, et al. MEFV-Gene analysis in armenian patients with familial Mediterranean fever: Diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype-genetic and therapeutic implications. Am J Hum Genet 1999; 65: 88-97. (Pubitemid 30470452)
28. Dode C, Hazenberg BP, Pecheux C, et al. Mutational spectrum in the MEFV and TNFRSF1A genes in patients suffering from AA amyloidosis and recurrent inflammatory attacks. Nephrol Dial Transplant 2002; 17: 1212-1217. (Pubitemid 34812065)
29. Gershoni-Baruch R, Brik R, Zacks N, Shinawi M, Lidar M, Livneh A. The contribution of genotypes at the MEFV and SAA1 loci to amyloidosis and disease severity in patients with familial Mediterranean fever. Arthritis Rheum 2003; 48: 1149-1155. (Pubitemid 36418258)
30. Shohat M, Magal N, Shohat T, et al. Phenotype-genotype correlation in familial Mediterranean fever: Evidence for an association between Met694Val and amyloidosis. Eur J Hum Genet 1999; 7: 287-292. (Pubitemid 29213734)